Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Feasibility of a Mobile Application to Support Reflection and Dialog About Strengths in People With Chronic Illness

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03437863
Recruitment Status : Completed
First Posted : February 19, 2018
Results First Posted : November 16, 2021
Last Update Posted : November 16, 2021
Sponsor:
Collaborators:
South-Eastern Norway Regional Health Authority
Diakonhjemmet Hospital
Information provided by (Responsible Party):
Elin Borosund, Oslo University Hospital

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Self-management of chronic illness can be highly demanding and people need to mobilize their personal strengths in order to live well with their condition. A mobile application was designed in collaboration with people with chronic illness and health care providers with the aims to support awareness of patients' strengths and patient-provider dialogues that include strengths. The aim of the present study is to evaluate with mixed methods the perceived usefulness and usability of the application and potential effects of the application on patients.

Condition or disease Intervention/treatment Phase
Chronic Disease Rheumatic Diseases Device: Mobile application Not Applicable

Detailed Description:
In this pre-post design pilot study participants will be recruited from self-management courses for people with rheumatic diseases. Before using the application participants will be asked to report their strengths in a written format. After using the mobile application to reflect on their strengths the participants will be interviewed about their experience of using the application and on the task of reflecting on their strengths. They will also be asked to fill out a questionnaire on perceived usefulness and user-friendliness. Before and after using the application the participants fill out questionnaires on emotions (Positive and Negative Affective Scale) and self-efficacy (The Arthritis Self-efficacy Scale). All interviews will be audio-taped and analyzed with a qualitative approach. Descriptive analysis will be applied for quantitative data.
Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 12 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Intervention Model Description: Participants will be recruited to a pre-post design study.
Masking: None (Open Label)
Primary Purpose: Device Feasibility
Official Title: Capitalizing on the Strengths of Persons With Rheumatoid Arthritis to Improve Health and Wellness
Actual Study Start Date : April 18, 2018
Actual Primary Completion Date : September 20, 2018
Actual Study Completion Date : September 20, 2018

Resource links provided by the National Library of Medicine


Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: Mobile application
Participants recruited from a self-management course are asked to use (single time) a mobile application to support reflection of personal strengths. The participant borrows an Ipad and uses the application to 1) reflect and identify their strengths by reviewing a list of examples, 2) define personal goals, and 3) link strengths to goals.
 Device: Mobile application
Use of a mobile application (on a borrowed device) with following features: 1) strengths reflection and identification, 2) summary of registered strengths, 3) defining goals, and 4) linking strengths to goals.


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Perceived Usefulness of the Application [ Time Frame: Within an hour after using the application ]
    Study-specific questions on perceived usefulness of the application

  2. The System Usability Scale [ Time Frame: Within an hour after using the application ]
    This 10 item questionnaire measures usability. Each item has 5 response options with total score ranging from 0 to 100. Higher values represent a better outcome.


Secondary Outcome Measures :
  1. The Positive and Negative Affect Schedule. [ Time Frame: Pre-intervention and post-intervention, within an hour after using the application ]
    This scale measures positive and negative affect with two subscales (positive affect and negative affect). Positive affect subscale scores can range from 10-50, with higher scores representing higher levels of positive affect. Negative affect subscale scores can range from 10-50, with lower scores representing lower levels of negative affect.

  2. The Arthritis Self-efficacy Scale [ Time Frame: Pre-intervention and post-intervention, within an hour after using the application ]
    This scale measures self-efficacy with two subscales with 5 response options. The "pain" subscale has 5 items and a score range from 0 to 20. The "other symptoms" subscale has 6 items and a score range from 0 to 24. Higher scores equal higher levels of self-efficacy.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 100 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Setting 1:

Inclusion Criteria:

  • Age of 18 years or older
  • Can read and speak Norwegian language
  • Diagnosed with a chronic condition
  • Participating or having recently participated in a learning and mastery or an outpatient rehabilitation program

No exclusion criteria

Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03437863


Locations
Layout table for location information
Norway
Diakonhjemmet Hospital
Oslo, Norway, 0370
Sponsors and Collaborators
Oslo University Hospital
South-Eastern Norway Regional Health Authority
Diakonhjemmet Hospital
Investigators
Layout table for investigator information
Principal Investigator: Olöf B Kristjansdottir, PhD Oslo University Hospital, Center for Shared Decision Making and Collaborative Care Research
  Study Documents (Full-Text)

Documents provided by Elin Borosund, Oslo University Hospital:
Study Protocol and Statistical Analysis Plan  [PDF] March 19, 2021

More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Elin Borosund, Principal Investigator, Oslo University Hospital
ClinicalTrials.gov Identifier: NCT03437863    
Other Study ID Numbers: 2015065
First Posted: February 19, 2018    Key Record Dates
Results First Posted: November 16, 2021
Last Update Posted: November 16, 2021
Last Verified: November 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Elin Borosund, Oslo University Hospital:
self-management
health assets
Strengths
mHealth
Feasibility
Additional relevant MeSH terms:
Layout table for MeSH terms
Rheumatic Diseases
Collagen Diseases
Chronic Disease
Disease Attributes
 Pathologic Processes
Musculoskeletal Diseases
Connective Tissue Diseases